secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001193125-23-299370
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics appoints former US Secretary of Commerce Wilbur L. Ross to board of directors
--------------------------------------------------------------------------------

- Board expanded to seven directors; Ross appointed Class I director effective Dec 19, 2023, term until 2026 annual meeting.
- Ross granted options for 10,000 shares at closing price on Jan 2, 2024, vesting on one-year anniversary of appointment.
- Coya will leverage Ross's 55+ years of investment banking, private equity, and government experience for strategic partnerships and capital markets.
- Ross served as 39th US Secretary of Commerce (2017-2021) and is former Chairman & CSO of WL Ross & Co.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523299370/0001193125-23-299370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312523299370/d562177d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-299370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer